S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
Better Than Oil Stocks (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
Better Than Oil Stocks (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
AI Stock Caught Trading Under Secret Name (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
Better Than Oil Stocks (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
Better Than Oil Stocks (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
AI Stock Caught Trading Under Secret Name (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
Better Than Oil Stocks (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
Better Than Oil Stocks (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
AI Stock Caught Trading Under Secret Name (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
Better Than Oil Stocks (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
Better Than Oil Stocks (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
AI Stock Caught Trading Under Secret Name (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
OTCMKTS:OPHLF

Ono Pharmaceutical (OPHLF) Stock Price, News & Analysis

$16.82
0.00 (0.00%)
(As of 02/23/2024 ET)
Today's Range
$16.82
$16.82
50-Day Range
$16.82
$17.90
52-Week Range
$16.66
$21.45
Volume
N/A
Average Volume
28 shs
Market Capitalization
$8.65 billion
P/E Ratio
9.09
Dividend Yield
N/A
Price Target
N/A

OPHLF stock logo

About Ono Pharmaceutical Stock (OTCMKTS:OPHLF)

Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia. The company also provides Glactiv tablets for type 2 diabetes; Forxiga tablets for diabetes; Onoact Intravenous Infusion for tachyarrhythmia; Opalmon tablets to treat peripheral circulatory disorder; Coralan for chronic heart failure; Orencia injections for rheumatoid arthritis; Rivastach patches for Alzheimer's disease; Ongentys tablets for Parkinson's disease; Parsabiv, an intravenous infusion for dialysis patients; Staybla tablets for overactive bladder; Onon capsules and Dry Syrups for bronchial asthma and allergic rhinitis; and JOYCLU intra-articular injection for the improvement of joint function, as well as Recalbon tablets for osteoporosis. In addition, it develops products for hepatocellular and urothelial carcinoma; ovarian, bladder, prostate, pancreatic, gastric, esophageal, colorectal, thyroid, cell lung, and breast cancer; acute myeloid leukemia; solid tumors; myelodysplastic syndrome; melanoma; T-cell lymphoma; tachyarrhythmia; pemphigus; scleroderma; seizures; diabetic polyneuropathy; neurodegenerative diseases; autoimmune diseases; narcolepsy; and thrombosis. The company has a collaboration with Adimab, LLC to discover novel antibody drugs; and a research collaboration with Turbine Ltd. to identify and validate novel oncology targets. The company was founded in 1717 and is headquartered in Osaka, Japan.

OPHLF Stock Price History

OPHLF Stock News Headlines

CEO of America's biggest bank has stern warning
CEO of America’s biggest bank says, “I’m not sure if the world is prepared” for what he believes is coming next.
Ono Pharmaceutical Ltd (4528)
ODP: A Value Play With Catalysts
CEO of America's biggest bank has stern warning
CEO of America’s biggest bank says, “I’m not sure if the world is prepared” for what he believes is coming next.
Nikkei Falls 0.4% Amid JPY Strength
Ono Pharmaceutical Co Ltd
Ono Pharmaceutical Co. (OPHLF) Upgraded to Buy: Here's Why
See More Headlines
Receive OPHLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ono Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/31/2024
Today
2/23/2024
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:OPHLF
Employees
3,761
Year Founded
N/A

Profitability

Net Income
$834.15 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.31 billion
Cash Flow
$1.87 per share
Book Value
$10.76 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.65
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Gyo Sagara (Age 66)
    CEO, President & Representative Director
    Comp: $917.76k
  • Mr. Masaki Ito
    Corp. Offcr. and Div. Dir. of Corp. Strategy & Planning, Bus. Mgmt., Fin. & Acc. Dept. and Corp. Tax
  • Takehiro Yamada
    Corporate Officer & Senior Director of Risk & Compliance Mgmt. Dept. and Risk Mgmt. Promotion Office
  • Masayuki Tanigawa
    Corporate Officer & Executive Director of Corporate Development & Strategy
  • Mr. Toichi Takino Ph.D. (Age 56)
    Senior Managing Executive Officer, Head of Research Division & Director
  • Mr. Toshihiro Tsujinaka (Age 60)
    Sr. EO, Executive Director of Sustainability Promotion Corporate Strategy & Planning and Director
  • Hiromu Habashita Ph.D.
    Corporate Officer, Dep. Executive Dir. of Discovery & Research and Research Center of Immunology
  • Kiyoaki Idemitsu (Age 60)
    Managing Executive Officer, GM of Development Division & Director
  • Shinji Takai M.D.
    Ph.D., Corporate Officer & Head of Medical Affairs
  • Satoshi Takahagi
    Corporate Officer and Executive Director of Sales, Marketing & Primary Care Business Division














OPHLF Stock Analysis - Frequently Asked Questions

How have OPHLF shares performed in 2024?

Ono Pharmaceutical's stock was trading at $17.6850 on January 1st, 2024. Since then, OPHLF stock has decreased by 4.9% and is now trading at $16.82.
View the best growth stocks for 2024 here
.

How were Ono Pharmaceutical's earnings last quarter?

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) posted its earnings results on Wednesday, January, 31st. The company reported $0.51 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.06. The firm had revenue of $888.42 million for the quarter. Ono Pharmaceutical had a net margin of 25.43% and a trailing twelve-month return on equity of 16.32%.

How do I buy shares of Ono Pharmaceutical?

Shares of OPHLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:OPHLF) was last updated on 2/24/2024 by MarketBeat.com Staff